Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
Other Current Liabilities
$0.39 Mil (As of Jun. 2016)

Cascadian Therapeutics Inc's other current liabilities for the quarter that ended in Jun. 2016 was $0.39 Mil.

Cascadian Therapeutics Inc's quarterly other current liabilities declined from Dec. 2015 ($0.15 Mil) to Mar. 2016 ($0.12 Mil) but then increased from Mar. 2016 ($0.12 Mil) to Jun. 2016 ($0.39 Mil).

Cascadian Therapeutics Inc's annual other current liabilities increased from Dec. 2013 ($0.19 Mil) to Dec. 2014 ($0.28 Mil) but then declined from Dec. 2014 ($0.28 Mil) to Dec. 2015 ($0.15 Mil).


The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Related Terms

Total Current Liabilities

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cascadian Therapeutics Inc Annual Data

Other Current Liab. -

Cascadian Therapeutics Inc Quarterly Data

Other Current Liab. 0.480.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)